Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHIT1 | Q13231 | 1/20 | 0.75 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.75 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.74 |
| ▸ | TNF | P01375 | 3/20 | 0.74 |
| ▸ | PDE4A | P27815 | 3/20 | 0.74 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.74 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.74 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.74 |
| ▸ | ACHE | P22303 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.74 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | GLA | P06280 | 1/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisdionin D SCHEMBL16120988 | 0.97 | ADORA2B (0.79) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL16120981 | 0.95 | ADORA2B (0.77) | CHIT1CHIAADORA2BTNFPDE4A | |
| Bisdionin B SCHEMBL29896692 | 0.93 | ADORA2B (0.74) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL3523033 | 0.92 | ADORA2B (0.69) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL516018 | 0.92 | PDE4A (0.78) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL7315040 | 0.91 | ADORA2B (0.67) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL11300380 | 0.91 | ADORA2B (0.71) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL9293614 | 0.91 | ADORA2B (0.71) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL11355557 | 0.91 | ADORA2B (0.67) | CHIT1CHIAADORA2BTNFPDE4A | |
| SCHEMBL266179 | 0.91 | PDE4A (0.72) | CHIT1CHIAADORA2BTNFPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439925-B2 | Anti-pathogenic activity of a bifunctional peptidoglycan/chitin hydrolase | UNIVERSITEIT ANTWERPEN (BE) | 2025-10-14 | — | — | US | disclosed |
| CN-119504753-A | Aromatic condensed ring imine compound, and preparation method and application thereof | 华东理工大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-114105986-B | Aromatic condensed ring diketone compound and preparation method and application thereof | 华东理工大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-116102553-A | Aromatic condensed ring imine compound, and preparation method and application thereof | 华东理工大学 | 2023-05-12 | — | — | CN | disclosed |
| US-20170349317-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20170349317-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-9764872-B2 | Gas barrier enhancing additives and methods | THE COCA-COLA COMPANY (US) | 2017-09-19 | — | — | US | disclosed |
| US-9764872-B2 | Gas barrier enhancing additives and methods | THE COCA-COLA COMPANY (US) | 2017-09-19 | — | — | US | disclosed |
| US-20160031583-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | CSPC INNOVATION PHARMACEUTICAL CO., LTD. (CN) | 2016-02-04 | — | — | US | disclosed |
| US-20160031583-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | CSPC INNOVATION PHARMACEUTICAL CO., LTD. (CN) | 2016-02-04 | — | — | US | disclosed |
| WO-2014152788-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA-COMPANY (US) | 2014-09-25 | — | — | WO | disclosed |
| US-8207175-B2 | Inhibitor compounds | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2012-06-26 | — | — | US | disclosed |
| US-20090215798-A1 | Inhibitor Compounds | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215798-A1 | Inhibitor Compounds | ENGASE, MAN2B2, CHIA | CHIT1 7/4885CHIA 3/4885ADORA2B 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.